[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100507832":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":25,"centralContacts":29,"locations":35,"responsibleParty":170,"collaborators":25,"id":172,"slug":25,"hasResults":173,"nctId":174,"briefTitle":175,"officialTitle":176,"acronym":25,"eligibilityCriteria":177,"healthyVolunteers":173,"sex":178,"minAge":179,"maxAge":25,"enrollmentInfo":180,"targetDuration":25,"studyType":183,"phases":184,"briefSummary":187,"conditions":188,"keywords":193,"overallStatus":38,"whyStopped":25,"lastUpdateSubmitDate":198,"lastUpdatePostDateStruct":199,"startDateStruct":202,"completionDateStruct":204,"leadSponsor":206,"locationsCount":207},{"fullName":5,"class":6},"University of Melbourne","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Placebo","PLACEBO_COMPARATOR","Intra-arterial bolus of placebo (0.9% Sodium Chloride solution) representing standard of care (no intra-arterial thrombolytic treatment).",[13],"Drug: Placebo",{"label":15,"type":16,"description":17,"interventionNames":18},"Intra-arterial tenecteplase injection at the completion of thrombectomy","EXPERIMENTAL","intra-arterial tenecteplase (0.062mg\u002Fkg, maximum 6.25mg) administered as a bolus at the completion of thrombectomy through a microcatheter at the site of the initial-but-now-retrieved intracranial occlusion or in direct contact with the residual thrombus",[19],"Drug: Intra-arterial tenecteplase injection at the completion of thrombectomy",[21,26],{"type":22,"name":15,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Intra-arterial tenecteplase (0.062mg\u002Fkg, maximum 6.25mg) administered as a bolus at the completion of thrombectomy through a microcatheter at the site of the initial-but-now-retrieved intracranial occlusion, or in direct contact with the residual thrombus",[15],null,{"type":22,"name":9,"description":27,"armGroupLabels":28,"otherNames":25},"intra-arterial bolus of 0.9% Sodium Chloride solution",[9],[30],{"name":31,"role":32,"phone":33,"phoneExt":25,"email":34},"Felix Ng","CONTACT","+03 9342 7000","ng.f@unimelb.edu.au",[36,51,65,78,87,96,105,117,125,137,146,157],{"facility":37,"status":38,"city":39,"state":40,"zip":25,"country":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"Gold Coast Univeristy Hospital","RECRUITING","Gold Coast","Queensland","Australia",{"type":43,"coordinates":44},"Point",[45,46],153.43088,-28.00029,{"lat":46,"lon":45},[49],{"name":50,"role":32,"phone":25,"phoneExt":25,"email":25},"Peter Bailey",{"facility":52,"status":38,"city":53,"state":25,"zip":25,"country":41,"cosmosGeoPoint":54,"geoPoint":58,"contacts":59},"Royal Adelaide Hospital","Adelaide",{"type":43,"coordinates":55},[56,57],138.59863,-34.92866,{"lat":57,"lon":56},[60,62],{"name":61,"role":32,"phone":25,"phoneExt":25,"email":25},"Roy Drew",{"name":63,"role":64,"phone":25,"phoneExt":25,"email":25},"Timothy Kleinig","PRINCIPAL_INVESTIGATOR",{"facility":66,"status":38,"city":67,"state":25,"zip":25,"country":41,"cosmosGeoPoint":68,"geoPoint":72,"contacts":73},"Alfred Hospital","Melbourne",{"type":43,"coordinates":69},[70,71],144.96332,-37.814,{"lat":71,"lon":70},[74,76],{"name":75,"role":32,"phone":25,"phoneExt":25,"email":25},"Pamela Galindo",{"name":77,"role":64,"phone":25,"phoneExt":25,"email":25},"Geoff Cloud",{"facility":79,"status":38,"city":67,"state":25,"zip":25,"country":41,"cosmosGeoPoint":80,"geoPoint":82,"contacts":83},"Austin Hospital",{"type":43,"coordinates":81},[70,71],{"lat":71,"lon":70},[84,86],{"name":85,"role":32,"phone":25,"phoneExt":25,"email":25},"Vincent Thijs",{"name":85,"role":64,"phone":25,"phoneExt":25,"email":25},{"facility":88,"status":38,"city":67,"state":25,"zip":25,"country":41,"cosmosGeoPoint":89,"geoPoint":91,"contacts":92},"Monash Medical Centre",{"type":43,"coordinates":90},[70,71],{"lat":71,"lon":70},[93,95],{"name":94,"role":32,"phone":25,"phoneExt":25,"email":25},"Henry Ma",{"name":94,"role":64,"phone":25,"phoneExt":25,"email":25},{"facility":97,"status":38,"city":67,"state":25,"zip":25,"country":41,"cosmosGeoPoint":98,"geoPoint":100,"contacts":101},"Royal Melbourne Hospital",{"type":43,"coordinates":99},[70,71],{"lat":71,"lon":70},[102,104],{"name":103,"role":32,"phone":25,"phoneExt":25,"email":25},"David Jackson",{"name":31,"role":64,"phone":25,"phoneExt":25,"email":25},{"facility":106,"status":38,"city":107,"state":25,"zip":25,"country":41,"cosmosGeoPoint":108,"geoPoint":112,"contacts":113},"Fiona Stanley Hospital","Perth",{"type":43,"coordinates":109},[110,111],115.8614,-31.95224,{"lat":111,"lon":110},[114,116],{"name":115,"role":32,"phone":25,"phoneExt":25,"email":25},"Darshan Ghia",{"name":115,"role":64,"phone":25,"phoneExt":25,"email":25},{"facility":118,"status":38,"city":107,"state":25,"zip":25,"country":41,"cosmosGeoPoint":119,"geoPoint":121,"contacts":122},"Sir Charles Gairdner Hospital",{"type":43,"coordinates":120},[110,111],{"lat":111,"lon":110},[123],{"name":124,"role":32,"phone":25,"phoneExt":25,"email":25},"Timothy Phillips",{"facility":126,"status":38,"city":127,"state":25,"zip":25,"country":41,"cosmosGeoPoint":128,"geoPoint":132,"contacts":133},"Liverpool Hospital","Sydney",{"type":43,"coordinates":129},[130,131],151.20732,-33.86785,{"lat":131,"lon":130},[134,136],{"name":135,"role":32,"phone":25,"phoneExt":25,"email":25},"Dennis Cordato",{"name":135,"role":64,"phone":25,"phoneExt":25,"email":25},{"facility":138,"status":38,"city":127,"state":25,"zip":25,"country":41,"cosmosGeoPoint":139,"geoPoint":141,"contacts":142},"Royal North Shore Hospital",{"type":43,"coordinates":140},[130,131],{"lat":131,"lon":130},[143,145],{"name":144,"role":32,"phone":25,"phoneExt":25,"email":25},"Alice Ma",{"name":144,"role":64,"phone":25,"phoneExt":25,"email":25},{"facility":147,"status":38,"city":148,"state":25,"zip":25,"country":41,"cosmosGeoPoint":149,"geoPoint":153,"contacts":154},"Townsville University Hospital","Townsville",{"type":43,"coordinates":150},[151,152],146.80569,-19.26639,{"lat":152,"lon":151},[155],{"name":156,"role":32,"phone":25,"phoneExt":25,"email":25},"Ravindra Urkude",{"facility":158,"status":159,"city":160,"state":25,"zip":25,"country":161,"cosmosGeoPoint":162,"geoPoint":166,"contacts":167},"Christchurch Hospital","NOT_YET_RECRUITING","Christchurch","New Zealand",{"type":43,"coordinates":163},[164,165],172.63333,-43.53333,{"lat":165,"lon":164},[168],{"name":169,"role":32,"phone":25,"phoneExt":25,"email":25},"Teddy Wu",{"type":171,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100507832",false,"NCT05892510","Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke","Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke (EXTEND-AGNES TNK)","Inclusion Criteria:\n\n* Adult participants (age≥18 years) presenting with ischemic stroke with arterial LVO on CT\u002FMR Angiogram of the intracranial internal carotid or middle cerebral artery (MCA) first segment (M1) or proximal second segment (M2) committed to thrombectomy using standard criteria within 24 hours of onset:\n* For 0-6 hours of symptom onset: Presence of arterial occlusion as defined above and ASPECTS≥3 on NCCT\n* For 6-24 hours of symptom onset: Additional imaging criteria on CTP or MRI perfusion of core volume \\\u003C100ml.\n* Qualifying CT\u002FMR within 4hrs of randomisation (repeat CT for transferred participants required if \\>4hr)\n* Pre-stroke Modified Rankin Scale (mRS) score of ≤2 (mild pre-existing disability permitted)\n* Local legal requirements for consent have been satisfied.\n\nExclusion Criteria:\n\n* Intracranial hemorrhage identified by CT or MRI\n* ASPECTS 0-2 on NCCT\n* CTP or MRI perfusion ischemic core volume \\>100ml if presenting within 6-24 hours from symptoms onset\n* Anticipated endovascular stenting required for intracranial or extracranial atherosclerotic stenosis\u002Focclusion.\n* More than six retrieval attempts in the same vessel\n* Alteplase being infused within 30 minutes (\\~5x half-life) of anticipated trial drug administration\n* Contraindication to imaging with contrast agents\n* Any condition (eg.mid-arterial phase early venous filling) that in the judgment of investigators could impose hazards if study therapy is initiated\n* Pregnant women.\n* Current participation in another intervention research study that includes experimental interventions beyond standard-of-care.\n* Anticoagulation. INR ≤1.7 if on warfarin, and dabigatran reversal by idarucizumab are permitted.\n* Other standard contraindications to thrombolysis apart from time window.\n* Known terminal illness such that the participants would not be expected to survive a year.\n* Planned withdrawal of care or comfort care measures.","ALL","18 Years",{"count":181,"type":182},462,"ESTIMATED","INTERVENTIONAL",[185,186],"PHASE2","PHASE3","Multicentre, prospective, Multi-arm Multi-stage (MAMS) seamless phase 2b\u002F3 interventional randomized placebo-controlled double-blinded parallel-assignment (2 arms with 1:1 randomization) efficacy and safety trial to test intra-arterial tenecteplase at the completion of thrombectomy versus best practice in participants with anterior circulation LVO receiving mechanical thrombectomy within 24 hours of symptoms onset.",[189,190,191,192],"Ischemic Stroke, Acute","Cerebrovascular Disorders","Brain Disorder","Central Nervous System Diseases",[194,195,196,197],"Tenecteplase","Fibrinolytic agents","Thrombectomy","No-reflow","2026-05-14",{"date":200,"type":201},"2026-05-18","ACTUAL",{"date":203,"type":201},"2024-06-01",{"date":205,"type":182},"2027-11-30",{"name":5,"class":6},12]